U.S. federal trademark · Serial No. 86172046 · Reg. No. 4588638
Laboratory testing services, namely providing prognostic and predictive tests to determine whether patients or a subgroup of patients are likely to benefit from treatment with therapies or combination of therapies intended to treat a disease or disorder, including anti-cancer drugs for cancer, based on mass spectral analysis of clinical specimens
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.